These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7882357)

  • 21. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimized polymerase chain reaction-based single-strand conformation polymorphism analysis of p53 gene applied to Bulgarian patients with invasive breast cancer.
    Krasteva ME; Garanina Z; Georgieva EI
    Clin Exp Med; 2003 Nov; 3(3):173-80. PubMed ID: 14648233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
    Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
    Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism.
    Iacopetta B; Elsaleh H; Grieu F; Joseph D; Sterrett G; Robbins P
    Diagn Mol Pathol; 2000 Mar; 9(1):20-5. PubMed ID: 10718209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 mutations and overexpression in locally advanced breast cancers.
    Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F
    Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of the p53 mutation in esophageal cancer.
    Uchino S; Saito T; Inomata M; Osawa N; Chikuba K; Etoh K; Kobayashi M
    Jpn J Clin Oncol; 1996 Oct; 26(5):287-92. PubMed ID: 8895666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple mutations of the p53 gene in human mammary carcinoma.
    Meng L; Lin L; Zhang H; Nassiri M; Morales AR; Nadji M
    Mutat Res; 1999 Dec; 435(3):263-9. PubMed ID: 10606817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
    Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 mutations and overexpressions in Japanese breast cancer.
    Fukushima T; Onda M; Abe R; Otake T; Kimijima I; Tsuchiya A
    Eur J Surg Oncol; 1995 Dec; 21(6):595-600. PubMed ID: 8631401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy.
    Chevillard S; Lebeau J; Pouillart P; de Toma C; Beldjord C; Asselain B; Klijanienko J; Fourquet A; Magdelénat H; Vielh P
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2471-8. PubMed ID: 9815649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan.
    Sasa M; Kondo K; Komaki K; Uyama T; Morimoto T; Monden Y
    Breast Cancer Res Treat; 1993 Sep; 27(3):247-52. PubMed ID: 8312582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social class and black-white differences in breast cancer survival.
    Bassett MT; Krieger N
    Am J Public Health; 1986 Dec; 76(12):1400-3. PubMed ID: 3777285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study Group.
    Kucera E; Speiser P; Gnant M; Szabo L; Samonigg H; Hausmaninger H; Mittlböck M; Fridrik M; Seifert M; Kubista E; Reiner A; Zeillinger R; Jakesz R
    Eur J Cancer; 1999 Mar; 35(3):398-405. PubMed ID: 10448289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
    Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R
    Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.
    Lisboa BW; Vogtländer S; Gilster T; Riethdorf L; Milde-Langosch K; Löning T
    Virchows Arch; 1997 Dec; 431(6):375-81. PubMed ID: 9428925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populations.
    Blaszyk H; Hartmann A; Tamura Y; Saitoh S; Cunningham JM; McGovern RM; Schroeder JJ; Schaid DJ; Ii K; Monden Y; Morimoto T; Komaki K; Sasa M; Hirata K; Okazaki M; Kovach JS; Sommer SS
    Oncogene; 1996 Nov; 13(10):2159-66. PubMed ID: 8950983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
    Isola J; Visakorpi T; Holli K; Kallioniemi OP
    J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
    Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
    J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
    Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
    J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.